Cargando…
The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers
Gastrointestinal cancers (GICs) occupy more than 30% of the cancer-related incidence and mortality around the world. Despite advances in the treatment strategies, the long-term overall survival has not been improved for patients with GICs. Recently, the novel patient-derived organoid (PDO) culture t...
Autores principales: | Yu, Ya-ya, Zhu, Yan-juan, Xiao, Zhen-zhen, Chen, Ya-dong, Chang, Xue-song, Liu, Yi-hong, Tang, Qing, Zhang, Hai-bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547471/ https://www.ncbi.nlm.nih.gov/pubmed/36207749 http://dx.doi.org/10.1186/s40364-022-00421-0 |
Ejemplares similares
-
An organoids biobank for recapitulating tumor heterogeneity and personalized medicine
por: Yang, Hui, et al.
Publicado: (2020) -
Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
por: Zhou, Zilong, et al.
Publicado: (2021) -
Peroxisome Proliferator–Activated Receptor-α: A Pivotal Regulator of the Gastrointestinal Tract
por: Guo, Yue-Xin, et al.
Publicado: (2022) -
Establishment of a patient-derived organoid model and living biobank for nasopharyngeal carcinoma
por: Wang, Xian-Wen, et al.
Publicado: (2022) -
Corrigendum: Peroxisome proliferator–activated receptor-α: A pivotal regulator of the gastrointestinal tract
por: Guo, Yue-Xin, et al.
Publicado: (2022)